Pharmaceutical News

RSS

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

Experts provide guidance on opioid management in individuals with cancer-related pain

Clinicians treating cancer-related pain must consider whether and how to prescribe opioids to patients who use nonmedical stimulants such as cocaine and methamphetamines; however, no guidelines exist related to these common and challenging situations.

15 Sep 2023

Chemotherapy drug could be repurposed to treat fatal heart failure, computer model suggests

A chemotherapy drug used to fight bone-marrow cancer also has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.

15 Sep 2023

Impact of prior SARS-CoV-2 infection and mRNA vaccination on contagiousness and infection risk

The study finds that natural SARS-CoV-2 infection offers stronger immunity against the virus compared to mRNA vaccines. However, mRNA vaccines significantly reduce the infectiousness of individuals with COVID-19, playing a crucial role in limiting the virus's transmission.

14 Sep 2023

Results from a nested randomized controlled trial for BCG vaccination against recurrent herpes labialis

Researchers examined the effect of Bacillus Calmette-Guérin (BCG) vaccination on attenuating herpes labialis (cold sore) recurrences.

14 Sep 2023

CDC recommendations for pneumococcal vaccine in adults

Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.

12 Sep 2023

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.

11 Sep 2023

Antidepressants may reduce negative memories, improve memory in depressed individuals

New research from Rice University finds that antidepressants may actually reduce negative memories in individuals suffering from depression while improving overall memory function.

11 Sep 2023

Vaccination amps up antibody response and cuts down COVID severity, UK study shows

UK study reveals COVID-19 vaccination effectively boosts anti-S antibody levels and reduces symptom severity post-infection, irrespective of the viral variant involved. High antibody levels are linked to quicker viral clearance, suggesting reduced transmission risk.

10 Sep 2023

Researchers use machine learning to predict drug approval chances before clinical trials

Developing new drugs is paramount in discovering innovative treatments and preventing diseases. This is vital not only for advancing medicine but also for the overall health and well-being of humanity.

8 Sep 2023

Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

8 Sep 2023

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

8 Sep 2023

New fund could incentivize development of high-priced drugs with weak clinical evidence

A new fund to fast-track patient access to potentially valuable new medicines may incentivize the pharmaceutical industry to develop high-priced drugs for rare diseases with weak evidence on clinical benefits.

7 Sep 2023

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in hospital settings.

7 Sep 2023

Antipsychotics are likely overprescribed among homebound patients with dementia, study shows

New research published in the Journal of the American Geriatrics Society indicates that antipsychotics are likely overprescribed and used inappropriately among patients with Alzheimer's disease and related dementias (ADRD) receiving home health care, and such use is linked to worse patient outcomes.

7 Sep 2023

Broad-spectrum antibiotics linked to higher sepsis risk in neonates

A preprint presents evidence for the hypothesis that neonatal sepsis is linked to prenatal antibiotics.

7 Sep 2023

Experimental insomnia treatment may help prevent opioid relapse

A good night's sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.

6 Sep 2023

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.

6 Sep 2023

Clovibactin - a game-changing novel antibiotic with no resistance

Researchers reported the discovery of a new antibiotic, clovibactin.

6 Sep 2023

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

New U.S. study finds mRNA-1273.815, a monovalent vaccine targeting the Omicron XBB.1.5 variant, generates higher neutralizing antibody titers compared to its bivalent counterpart. The study supports updating to an XBB.1.5-based monovalent vaccine for the 2023-24 campaign to combat emerging variants.

5 Sep 2023

Previous
1
...
39
40
41
42
43
44
45
...
1433
Next

Pharmaceutical News

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

Experts provide guidance on opioid management in individuals with cancer-related pain

Chemotherapy drug could be repurposed to treat fatal heart failure, computer model suggests

Impact of prior SARS-CoV-2 infection and mRNA vaccination on contagiousness and infection risk

Results from a nested randomized controlled trial for BCG vaccination against recurrent herpes labialis

CDC recommendations for pneumococcal vaccine in adults

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antidepressants may reduce negative memories, improve memory in depressed individuals

Vaccination amps up antibody response and cuts down COVID severity, UK study shows

Researchers use machine learning to predict drug approval chances before clinical trials

Research review focuses on the use of psilocybin for treatment of depression

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

New fund could incentivize development of high-priced drugs with weak clinical evidence

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Antipsychotics are likely overprescribed among homebound patients with dementia, study shows

Broad-spectrum antibiotics linked to higher sepsis risk in neonates

Experimental insomnia treatment may help prevent opioid relapse

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Clovibactin - a game-changing novel antibiotic with no resistance

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News